Muwonga Tukisadila Jonathan, Mboumba Bouassa Ralph-Sydney, Tonen-Wolyec Serge, Loemba Hugues, Muwonga Jeremie, Belec Laurent
École Doctorale Régionale D'Afrique Centrale en Infectiologie Tropicale, Franceville 876, Gabon.
Laboratoire de Biologie Clinique des Cliniques Universitaires de Kinshasa, Kinshasa 123, Democratic Republic of the Congo.
Trop Med Infect Dis. 2025 Jun 7;10(6):157. doi: 10.3390/tropicalmed10060157.
BACKGROUND: Female sex workers (FSWs) in sub-Saharan Africa bear a disproportionate burden of sexually transmitted infections, including HIV, high-risk HPV (HR-HPV), and herpes simplex virus type 2 (HSV-2). This study evaluated possible association between HR-HPV, HIV, and HSV-2 among FSWs in the Democratic Republic of the Congo. METHODS: A cross-sectional study was conducted among 432 FSWs (mean age, 28.1 years) recruited via respondent-driven sampling. Genital self-sampling using the V-Veil UP2™ device was performed, followed by HPV genotyping and quantification by multiplex PCR, and HSV-2 DNA detection by PCR. RESULTS: Among 415 participants, HR-HPV prevalence was 36.9%, with HPV-52 (14.9%), HPV-58 (10.1%), and HPV-16 (6.5%) as leading genotypes. Overall, 89% of HR-HPV-positive women harbored genotypes covered by Gardasil-9. Co-infection with HIV and HSV-2 significantly increased HPV prevalence, genotype diversity, and viral load. Notably, HSV-2 positivity was the sole independent predictor of elevated replication of HR-HPV ( < 0.001), vaccine HR-HPV ( < 0.001), and non-vaccine HR-HPV ( < 0.021). CONCLUSIONS: FSWs exhibit a high burden of HR-HPV, shaped by co-infections with HIV and HSV-2. HSV-2 independently drives HR-HPV replication, highlighting its role in HPV persistence and cervical cancer risk. Integrated HSV-2 detection and Gardasil-9 vaccination should be prioritized in cervical cancer elimination strategies targeting high-risk populations in sub-Saharan Africa.
背景:撒哈拉以南非洲的女性性工作者承受着包括艾滋病毒、高危型人乳头瘤病毒(HR-HPV)和2型单纯疱疹病毒(HSV-2)在内的性传播感染的不成比例负担。本研究评估了刚果民主共和国女性性工作者中HR-HPV、艾滋病毒和HSV-2之间可能存在的关联。 方法:通过应答者驱动抽样招募了432名女性性工作者(平均年龄28.1岁)进行横断面研究。使用V-Veil UP2™ 装置进行生殖器自我采样,随后通过多重聚合酶链反应进行HPV基因分型和定量,并通过聚合酶链反应检测HSV-2 DNA。 结果:在415名参与者中,HR-HPV患病率为36.9%,其中HPV-52(14.9%)、HPV-58(10.1%)和HPV-16(6.5%)为主要基因型。总体而言,89%的HR-HPV阳性女性携带九价重组人乳头瘤病毒疫苗(Gardasil-9)涵盖的基因型。艾滋病毒和HSV-2的合并感染显著增加了HPV患病率、基因型多样性和病毒载量。值得注意的是,HSV-2阳性是HR-HPV(P<0.001)、疫苗型HR-HPV(P<0.001)和非疫苗型HR-HPV(P<0.021)复制增加的唯一独立预测因素。 结论:女性性工作者表现出较高的HR-HPV负担,这是由艾滋病毒和HSV-2的合并感染所导致的。HSV-2独立驱动HR-HPV复制,突出了其在HPV持续感染和宫颈癌风险中的作用。在撒哈拉以南非洲针对高危人群的宫颈癌消除策略中,应优先进行HSV-2检测和九价重组人乳头瘤病毒疫苗(Gardasil-9)接种。
Trop Med Infect Dis. 2025-6-7
Cochrane Database Syst Rev. 2012-6-13
Cochrane Database Syst Rev. 2018-5-9
Front Cell Infect Microbiol. 2024-12-4